Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of Recognized Stock Based Compensation

For the three and nine months ended September 30, 2024 and 2023, the Company recognized stock-based compensation expense as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(Amounts in 000’s)	2024		2023		2024		2023
Employee compensation:
Stock compensation expense	$	19	$	85	$	85	$	321
Total employee stock-based compensation expense	$	19	$	85	$	85	$	321

Summary of Company's Restricted Stock Activity

The following table summarizes the Company's restricted stock activity for the nine months ended September 30, 2024:

	Number of Shares (000's)			Weighted Avg. Grant Date (per Share) Fair Value
Unvested, December 31, 2023		80		$	5.27
Granted		65		$	2.18
Vested		(43	)	$	6.67
Forfeited		(16	)	$	3.15
Unvested, September 30, 2024		86		$	2.61

Summary of Company's Stock Option Activity

The following summarizes the Company's employee and non-employee stock option activity for the nine months ended September 30, 2024:

	Number of Shares (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (000's)
Outstanding, December 31, 2023		33	$	14.84			$	—
Granted		24	$	2.03
Outstanding, September 30, 2024		57	$	9.41		7.5	$	—
Outstanding and Vested, September 30, 2024		44	$	11.55		6.9	$	—

Schedule of Exercise Price Range

The following summary information reflects stock options outstanding, vested, and related details as of September 30, 2024:

	Stock Options Outstanding						Stock Options Exercisable
Exercise Price	Number of Shares (000's)		Weighted Average Remaining Contractual Term (in years)		Weighted Average Exercise Price		Shares Vested, September 30, 2024 (000's)		Weighted Average Exercise Price
$2.03-$3.32		48		8.8	$	2.68		35	$	2.91
$46.80 - $48.72		9		0.2	$	46.80		9	$	46.80
Total		57		7.5	$	9.41		44	$	11.55

Warrants

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Common Stock Warrant Activity

The following summarizes the Company's employee and non-employee common stock warrant as of December 31, 2023 and September 30, 2024:

	Outstanding and Exercisable
	Number of Shares (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)
Outstanding and Vested, December 31, 2023		32	$	52.50		1.0
Outstanding and Vested, September 30, 2024		32	$	52.50		0.3